[HIV-1 polymorphism and development of resistance mutations against non-nucleoside reverse transcriptase inhibitor, efavirenz].
Gatanaga
Hiroyuki
H
D000480:Alkynes; D019380:Anti-HIV Agents / Q000494:pharmacology; D048588:Benzoxazines; D003521:Cyclopropanes; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D009154:Mutation / Q000187:drug effects; D010078:Oxazines / Q000494:pharmacology*; D011110:Polymorphism, Genetic; D011480:Protease Inhibitors / Q000494:pharmacology; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D015215:Zidovudine / Q000494:pharmacology
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; C098320:efavirenz